MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
- 1 September 2018
- journal article
- review article
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 7 (S4) , S411-S419
Abstract
Active surveillance (AS) for prostate cancer (PCa) is generally considered to be a safe strategy for men with low-risk, localized disease. However, as many as 1 in 4 patients may be incorrectly classified as AS-eligible using traditional inclusion criteria. The use of multiparametric magnetic resonance imaging (mpMRI) may offer improved risk stratification in both the initial diagnostic and disease monitoring setting. We performed a review of recently published studies to evaluate the utility of this imaging modality for this clinical setting. An English literature search was conducted on PubMed for original investigations on localized PCa, AS, and magnetic resonance imaging. Our Boolean criteria included the following terms: PCa, AS, imaging, MRI, mpMRI, prospective, retrospective, and comparative. Our search excluded publication types such as comments, editorials, guidelines, reviews, or interviews. Our literature review identified 71 original investigations. Among these, 52 met our inclusion criteria. Evidence suggests mpMRI improves characterization of clinically significant prostate cancer (csPCa) foci, and the enhanced detection and risk-stratification afforded by this modality may keep men from being inappropriately placed on AS. Use of serial mpMRI may also permit longer intervals between confirmatory biopsies. Multiple studies demonstrate the benefit of MRI-targeted biopsies. The use of mpMRI of the prostate offers improved confidence in risk-stratification for men with clinically low-risk PCa considering AS. While on AS, serial mpMRI and MRI-targeted biopsy aid in the detection of aggressive disease transformation or foci of clinically-significant cancer undetected on prior biopsy sessions.Keywords
This publication has 69 references indexed in Scilit:
- Current status of magnetic resonance imaging ( MRI ) and ultrasonography fusion software platforms for guidance of prostate biopsiesBJU International, 2013
- Role of multiparametric 3.0‐ T esla magnetic resonance imaging in patients with prostate cancer eligible for active surveillanceBJU International, 2013
- Limitations of Basing Screening Policies on Screening TrialsMedical Care, 2013
- Normal Central Zone of the Prostate and Central Zone Involvement by Prostate Cancer: Clinical and MR Imaging ImplicationsRadiology, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance ProtocolsUrology, 2010
- Pathological Upgrading and Up Staging With Immediate Repeat Biopsy in Patients Eligible for Active SurveillanceJournal of Urology, 2008
- Central Zone Carcinoma of the Prostate Gland: A Distinct Tumor Type With Poor Prognostic FeaturesJournal of Urology, 2008
- Upgrading and Downgrading of Prostate Needle Biopsy Specimens: Risk Factors and Clinical ImplicationsUrology, 2007
- 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate CancerJAMA, 2005